Literature DB >> 11316846

Identification of a novel nuclear guanosine triphosphate-binding protein differentially expressed in renal disease.

Nicholas J Laping1, Barbara A Olson1, Yuan Zhu2.   

Abstract

A novel guanosine triphosphate-binding protein, chronic renal failure gene (CRFG), was discovered by differential display PCR to be regulated differentially in renal disease. Within the rat kidney, CRFG mRNA was localized to the outer medulla and was highly expressed in epithelial cells. The specific renal expression of CRFG mRNA in the outer medulla was reduced dramatically in several rat models of renal disease, including diabetic nephropathy, partial nephrectomy, ischemia, and anti-Thy1.1-induced nephritis. CRFG was localized selectively in the nucleus of human and rodent cells, as determined by immunocytochemistry and green fluorescence fusion protein. Cellular mRNA levels of CRFG were also increased after serum administration, when cells proliferate. These data suggest that CRFG may be involved in regulating guanosine triphosphate-dependent nuclear events that are associated with cell proliferation and that are important in normal renal function and essential for growth and development.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11316846     DOI: 10.1681/ASN.V125883

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  10 in total

1.  Proteomic analysis of human metaphase chromosomes reveals topoisomerase II alpha as an Aurora B substrate.

Authors:  Ciaran Morrison; Alexander J Henzing; Ole Nørregaard Jensen; Neil Osheroff; Helen Dodson; Stefanie E Kandels-Lewis; Richard R Adams; William C Earnshaw
Journal:  Nucleic Acids Res       Date:  2002-12-01       Impact factor: 16.971

Review 2.  The perichromosomal layer.

Authors:  Aaron A Van Hooser; Patrick Yuh; Rebecca Heald
Journal:  Chromosoma       Date:  2005-11-15       Impact factor: 4.316

3.  Molecular biomarkers and adaptation to environmental stress in moon jelly (Aurelia spp.).

Authors:  Werner Schroth; Andrea Ender; Bernd Schierwater
Journal:  Mar Biotechnol (NY)       Date:  2005-06-04       Impact factor: 3.619

4.  Developmental changes in histone macroH2A1-mediated gene regulation.

Authors:  Lakshmi N Changolkar; Carl Costanzi; N Adrian Leu; Dannee Chen; K John McLaughlin; John R Pehrson
Journal:  Mol Cell Biol       Date:  2007-01-22       Impact factor: 4.272

5.  Restricting conformational flexibility of the switch II region creates a dominant-inhibitory phenotype in Obg GTPase Nog1.

Authors:  Yevgeniya R Lapik; Julia M Misra; Lester F Lau; Dimitri G Pestov
Journal:  Mol Cell Biol       Date:  2007-09-04       Impact factor: 4.272

6.  TOR regulates late steps of ribosome maturation in the nucleoplasm via Nog1 in response to nutrients.

Authors:  Yoshimi Honma; Aiko Kitamura; Ryo Shioda; Hironori Maruyama; Kanako Ozaki; Yoko Oda; Thierry Mini; Paul Jenö; Yasushi Maki; Kazuyoshi Yonezawa; Ed Hurt; Masaru Ueno; Masahiro Uritani; Michael N Hall; Takashi Ushimaru
Journal:  EMBO J       Date:  2006-08-03       Impact factor: 11.598

7.  Gene expression in the adapting small bowel after massive small bowel resection.

Authors:  Lyrissa Baksheev; Peter J Fuller
Journal:  J Gastroenterol       Date:  2006-12-08       Impact factor: 7.527

8.  Determining the Clinical Value and Critical Pathway of GTPBP4 in Lung Adenocarcinoma Using a Bioinformatics Strategy: A Study Based on Datasets from The Cancer Genome Atlas.

Authors:  Zhiqian Zhang; Juan Wang; Jiayan Mao; Fangqiong Li; Wei Chen; Wei Wang
Journal:  Biomed Res Int       Date:  2020-10-19       Impact factor: 3.411

9.  Nucleolar GTPase NOG-1 regulates development, fat storage, and longevity through insulin/IGF signaling in C. elegans.

Authors:  Young-Il Kim; Jaya Bandyopadhyay; Injeong Cho; Juyeon Lee; Dae Ho Park; Jeong Hoon Cho
Journal:  Mol Cells       Date:  2014-01-27       Impact factor: 5.034

10.  Knockdown of GTPBP4 inhibits cell growth and survival in human hepatocellular carcinoma and its prognostic significance.

Authors:  Wen-Bin Liu; Wei-Dong Jia; Jin-Liang Ma; Ge-Liang Xu; Hang-Cheng Zhou; Yan Peng; Wei Wang
Journal:  Oncotarget       Date:  2017-10-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.